In 2022, the Food and Drug Administration approved tirzepatide for prescription as a treatment for Type 2 diabetes
Afamelanotide was carried down the full pharmaceutical pathway: a defined molecule, a slow-release implant formulation, controlled clinical trials, and eventually orphan-drug approval for a rare disease
In response to the rampant smuggling of GLP-1 drugs into Taiwan, FDA Deputy Director-General Wang Te-yuan () stated that the illegal sources of slimming injections mainly fall into two categories: those carried into the country by travelers and those purchased online
Ethics declarations Conflict of Interest The authors declare that they have no conflicts of interest
This reflects the chronic biology of obesity rather than a failure of the individual and reinforces that long-term treatment is often needed
Bottom line: Zinc from Availa-Zn Reduces Intestinal Inflammation Inflammation and the bodys response to inflammation comes at a cost